Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023

腫瘍栄養の世界市場予測(~2023年)

◆タイトル:Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
◆商品コード:PH6225
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年4月30日
◆ページ数:97
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、腫瘍栄養の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、腫瘍種類別分析、地域別分析、腫瘍栄養の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The oncology nutrition market is projected to grow at a CAGR of 8.7% between 2018 and 2023.”The oncology nutrition market is expected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. The overall growth of the market is largely driven by the shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions. The development of elemental formulas and product innovation in this field also provides significant growth opportunities in this market. However, the complications associated with tube feeding and limited reimbursement represent significant challenges to the market growth.
“The head and neck cancers segment is expected to grow at the fastest rate during the forecast period.”
Based on cancer type, the oncology nutrition market is segmented into head & neck cancers, stomach & gastrointestinal cancers, pancreatic cancer, liver cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and other cancers. The head & neck cancers segment is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the increasing incidence of head and neck cancers across the globe. Such patients see the major use of feeding formulas as severe conditions such as mucositis, xerostomia, dysgeusia, nausea, and vomiting limit their nutritional intake.
“APAC to witness the highest growth during the forecast period.”
Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America commanded a major share of the oncology nutrition market. However, Asia Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia Pacific market is mainly attributed to the growing prevalence of chronic diseases & disorders, increasing number of preterm births, rising geriatric population, and increasing healthcare expenditure.
Break of primary participants:
• By Company Type – Tier 1: 48%, Tier 2–34%, and Tier 3–18%
• By Designation – C-suite: 32%, Director and Manager Level: 48%, and Executives and Others: 20%
• By Region – North America: 36%, Europe: 27%, Asia Pacific: 21%, and the Rest of the World: 16%
The players competing in this market are Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B.Braun Melsungen AG (Germany). The other players in this market include Mead Johnson Nutrition Company (US), Hormel Foods (US), Meiji Holdings (Japan), Victus (US), and Global Health Products (US).
Research Coverage:
The report analyzes the various types of nutritional formulas for cancer in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the oncology nutrition market for different cancer types and region. The report also includes in-depth company profiles of the key players in this market along with their product offerings, recent developments, and market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned four strategies for strengthening their market position.
The report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the oncology nutrition market
 Product Development/Innovation: Detailed insights on the research and development activities and new product launches in the oncology nutrition market
 Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the oncology nutrition market
 Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the oncology nutrition market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 9
1.1 OBJECTIVES OF THE STUDY 10
1.2 MARKET COVERED 10
1.3 MARKET DEFINITION 10
1.4 YEARS CONSIDERED 10
2 RESEARCH METHODOLOGY 11
2.1 SECONDARY RESEARCH 12
2.2 PRIMARY RESEARCH 13
2.3 ANALYSIS 16
3 MARKET DYNAMICS 17
3.1 DRIVERS 19
3.2 RESTRAINTS 23
3.3 OPPORTUNITIES 24
4 INDUSTRY INSIGHTS 26
4.1 CLINICAL CHALLENGES 27
4.2 MARKET CHALLENGES 28
4.3 PRODUCT ATTRIBUTES ASSESSMENT 29
4.4 INSIGHTS OF INDUSTRY EXPERTS 30
5 GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE 31
5.1 OVERVIEW – CANCER 32
5.2 MARKET SIZE, BY CANCER TYPE 36
5.3 HEAD AND NECK CANCER 39
5.4 STOMACH AND GASTROINTESTINAL CANCERS 42
5.5 LIVER CANCER 44
5.6 PANCREATIC CANCER 46
5.7 ESOPHAGEAL CANCER 49
5.8 LUNG CANCER 51
5.9 BREAST CANCER 53
5.10 BLOOD CANCER 55
5.11 OTHER CANCERS 57
6 PRODUCT PORTFOLIO ASSESSMENT 59
7 COMPANY PROFILES 64
(Business Overview, Company Snapshot, Financial Review, Products Offered, Recent Developments, MnM View)
7.1 ABBOTT LABORATORIES 65
7.2 NESTLÉ 72
7.3 DANONE 79
7.4 FRESENIUS KABI 84
7.5 B. BRAUN 88
8 MARKET SHARE ANALYSIS 92

LIST OF TABLES

TABLE 1 GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE, 2016–2023 (USD MILLION) 37
TABLE 2 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 38
TABLE 3 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR HEAD & NECK CANCERS, BY COUNTRY, 2016–2023 (USD MILLION) 41
TABLE 4 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR STOMACH & GASTROINTESTINAL CANCERS, BY COUNTRY, 2016–2023 (USD MILLION) 43
TABLE 5 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR LIVER CANCER, BY COUNTRY, 2016–2023 (USD MILLION) 45
TABLE 6 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2016–2023 (USD MILLION) 48
TABLE 7 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2016–2023 (USD MILLION) 50
TABLE 8 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR LUNG CANCER, BY COUNTRY, 2016–2023 (USD MILLION) 52
TABLE 9 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR BREAST CANCER, BY COUNTRY, 2016–2023 (USD MILLION) 54
TABLE 10 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR BLOOD CANCER, BY COUNTRY, 2016–2023 (USD MILLION) 56
TABLE 11 GLOBAL NUTRITIONAL FEEDING FORMULAS MARKET FOR OTHER CANCERS, BY COUNTRY, 2016–2023 (USD MILLION) 58


LIST OF FIGURES

FIGURE 1 GLOBAL CANCER INCIDENCE, 2008–2030 32
FIGURE 2 CANCER INCIDENCE ACROSS KEY COUNTRIES, 2012 33
FIGURE 3 SHARE OF GERIATRIC POPULATION AMONG NEW CANCER CASES 34
FIGURE 4 SMOKING PREVALENCE, BY COUNTRY, 2015 (% OF TOTAL POPULATION) 34
FIGURE 5 ESTIMATED NUMBER OF NEW CANCER CASES 35
FIGURE 6 GLOBAL ONCOLOGY NUTRITIONAL FEEDING FORMULAS MARKET, BY CANCER TYPE, 2018 VS 2023 36
FIGURE 7 HEAD & NECK CANCERS INCIDENCE, 2012–2030 39
FIGURE 8 HEAD & NECK CANCERS INCIDENCE ACROSS KEY REGIONS, 2012 40
FIGURE 9 STOMACH CANCER INCIDENCE, 2012–2030 42
FIGURE 10 STOMACH CANCER INCIDENCE ACROSS KEY REGIONS, 2012 42
FIGURE 11 LIVER CANCER INCIDENCE, 2012–2030 44
FIGURE 12 LIVER CANCER INCIDENCE ACROSS KEY REGIONS, 2012 44
FIGURE 13 PANCREATIC CANCER INCIDENCE, 2012–2030 46
FIGURE 14 PANCREATIC CANCER INCIDENCE ACROSS KEY REGIONS, 2012 46
FIGURE 15 ESOPHAGEAL CANCER INCIDENCE, 2012–2030 47
FIGURE 16 ESOPHAGEAL CANCER INCIDENCE ACROSS KEY REGIONS, 2012 49
FIGURE 17 LUNG CANCER INCIDENCE, 2012–2030 49
FIGURE 18 LUNG CANCER INCIDENCE ACROSS KEY REGIONS, 2012 51
FIGURE 19 BREAST CANCER INCIDENCE, 2012–2030 51
FIGURE 20 BREAST CANCER INCIDENCE ACROSS KEY REGIONS, 2012 53
FIGURE 21 BLOOD CANCER INCIDENCE, 2012–2030 53
FIGURE 22 BLOOD CANCER INCIDENCE ACROSS KEY REGIONS, 2012 55
FIGURE 23 NUTRITIONAL FEEDING FORMULAS: MARKET SHARE ASSESSMENT, 2015 VS 2017 VS 2023 93


【レポートのキーワード】

腫瘍栄養、癌、非経口栄養、経腸栄養

★調査レポート[腫瘍栄養の世界市場予測(~2023年)] ( Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023 / PH6225) 販売に関する免責事項
[腫瘍栄養の世界市場予測(~2023年)] ( Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023 / PH6225) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆